OneMedNet Enters Non-Exclusive Three-year Master Services Agreement With An Undisclosed US-Based Medical Technology Company; No Terms Disclosed
Portfolio Pulse from Benzinga Newsdesk
OneMedNet has entered into a non-exclusive three-year Master Services Agreement with an undisclosed US-based medical technology company. The agreement involves the use of OneMedNet's iRWD™ platform to manage clinical data under a fee-for-service model.
May 29, 2024 | 8:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
OneMedNet has signed a three-year Master Services Agreement with an undisclosed US-based medical technology company. The agreement will see OneMedNet's iRWD™ platform used to manage clinical data under a fee-for-service model.
The agreement is likely to positively impact OneMedNet's stock price in the short term due to the potential revenue from the fee-for-service model and the validation of its iRWD™ platform by a new customer.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100